Healthcare -
Biotechnology - NASDAQ - US
$ 128.0
0.361 %
$ 6.24 B
Market Cap
-21.33
P/E
AXSM - SHORT-TERM DEBT
Short-term Debt AXSM - Axsome Therapeutics, Inc.
1.84 M
LAST VALUE
107.79%
2 YEAR CAGR
-6.75%
5 YEAR CAGR
46.08%
10 YEAR CAGR